Please Login or Register

Login|Register FREE

Please Login or Register

Login|Register FREE

About ALPN

Nivalis Therapeutics, Inc. (http://www.nivalis.com) is a clinical stage pharmaceutical company committed to the discovery, development and commercialization of therapeutics for people with cystic fibrosis. In addition to developing innovative solutions intended to extend and improve the lives of people with cystic fibrosis, Nivalis plans to utilize its proprietary S-nitrosoglutathione reductase (GSNOR) inhibitor portfolio to develop therapeutics for other diseases.
Primary Exchange: NASDAQ
SIC Pharmaceutical Preparations
NAICS Pharmaceutical Preparation Manufacturing

ALPN is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
ITOT iShares Core S&P Total U.S. Stock Market ETF 15.1 B 1.51286E+10 3,419 3419 0.0% 0 4 K 3554
IWC iShares Microcap ETF 888.5 M 8.88541E+08 1,449 1449 0.01% 0.0001 59 K 59162
WMCR Invesco Wilshire Micro-Cap ETF 25.5 M 2.55E+07 1,085 1085 0.04% 0.00038 10 K 9989

Wait, Before You Leave...